.jpg "Chronic Wounds Market")
Chronic Wounds Overview
Chronic wounds are characterized as those that cannot heal in the expected amount of time. They are frequently abused and pervasive. When a wound has not entirely healed even after four to six weeks of screening, it is regarded as chronic or non-healing. Examples of typical chronic wound types include venous ulcers (VU [Vein ulcers, arterial ulcers], diabetic foot ulcers (DFU), and pressure ulcers (PU).
Chronic Wounds Epidemiology Insights (2021)
The Total Diagnosed Prevalent Cases of Chronic wounds in the 7MM were 7 million cases (approx)
Chronic Wounds Epidemiology Segmentation in the 7MM from 2019 to 2032
- Total Diagnosed Prevalent Cases
- Type-specific Diagnosed Prevalent Cases
Chronic Wounds Market Insight (2021)
The Chronic Wounds Market size in the 7MM was valued ~USD 5,232 million in 2021
Chronic Wounds Emerging Drugs and Companies
- Adipose Derived Regenerative Cells (ADRCs): Paracrine, Inc.
- ON101: Oneness Biotech
- TTAX01: Biotissue
- SkinTE: PolarityTE
- EscharEx: MediWound
- ALLO-ASC-DFU: Anterogen Co., Ltd.
- TR-987: TR Therapeutics
- Allo-APZ2: RHEACELL GmbH & Co. KG, and others